GlassScriptPhysician profile
Justin Gusching
NPI 1386919934
$4,119.23
in general payments reported to CMS, 2019-2025
13 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,459 · 2020: $306 · 2021: $228 · 2022: $98.65 · 2023: $277 · 2024: $355 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,600.55 | 2019-2021 | |
| Mentor Worldwide LLC | $420.35 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $376.02 | 2023-2025 | |
| Galderma Laboratories, L.P. | $208.72 | 2020-2025 | |
| Revance Therapeutics, INC. | $153.15 | 2024-2025 | Daxxify |
| Apollo Endosurgery US INC | $139.86 | 2019-2021 | |
| Apyx Medical Corporation | $49.52 | 2020 | |
| Organogenesis INC. | $41.36 | 2023 | Puraply |
| Solta Medical, A Division of Bausch Health US, LLC | $37.90 | 2021-2025 | |
| Lifenet Health | $37.35 | 2024 | Theragenesis Wound Matrix |
| Kowa Pharmaceuticals America, INC. | $19.68 | 2023 | Seglentis |
| Medline Industries LP | $18.04 | 2022 | |
| Bioventus LLC | $16.73 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Gusching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.